Intradermal sterile water injection versus diclofenac sodium in acute renal colic pain: A randomized controlled trial.
Acute Disease
Adult
Anti-Inflammatory Agents, Non-Steroidal
/ administration & dosage
Contrast Media
Diclofenac
/ administration & dosage
Double-Blind Method
Emergency Service, Hospital
Female
Humans
Injections, Intradermal
Injections, Intramuscular
Male
Middle Aged
Pain Management
/ methods
Pain Measurement
Renal Colic
/ diagnostic imaging
Tomography, X-Ray Computed
Water
/ administration & dosage
Diclofenac
Renal colic
Sterile water injection
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
07
04
2020
revised:
14
04
2020
accepted:
24
04
2020
pubmed:
24
5
2020
medline:
22
6
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
We aimed to evaluate the efficacy of intracutaneous sterile water injection (ISWI) to relieve the pain of acute renal colic compared with diclofenac and placebo. The study included 150 patients presented to the Emergency Department with renal colic randomized into 3 groups: control group received intracutaneous injections of 0.5 cm The mean baseline pain score was 9.6 ± 0.61 in the ISWI group, 9.72 ± 0.64 in the diclofenac group and 9.26 ± 0.89 in the control group. The mean pain score at 30 min of the control group was reduced to 6.9 ± 1.56. This mean at 30 min after ISWI and diclofenac injections were reduced to 1.98 ± 1.41 and 1.88 ± 1.19 respectively. The mean of pain sore of the ISWI and diclofenac group at 45 and 60 min was constant. Rescue analgesics at 1 h were required by 47 patients receiving the saline injection and by 4 patients and by 7 patients receiving ISWI and diclofenac injection respectively. ISWI and diclofenac were equally effective for the pain relief of acute renal colic.
Identifiants
pubmed: 32444296
pii: S0735-6757(20)30309-0
doi: 10.1016/j.ajem.2020.04.079
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Contrast Media
0
Water
059QF0KO0R
Diclofenac
144O8QL0L1
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
395-400Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no competing interests.